ArticleMolecular therapy. Methods & clinical development2019

ALPPL2 Is a Potential Diagnostic Biomarker for Pancreatic Cancer-Derived Extracellular Vesicles.

Hye-Su Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.